American Journal of Cancer Research-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2192065, encodeId=a9272192065d0, content=2024-1-10投稿至今两个多月还在under review 之前邮件说是审稿4-8周的啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da775330396, createdName=148ca721m03暂无昵称, createdTime=Fri Mar 08 12:47:13 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198484, encodeId=f76d21984843d, content=偏重的研究方向：肿瘤 经验分享：目前这个杂志一审需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231020/9a7cba30b8b140c78120c7acf9c0c8c2/5b6deb3cbcd44c788f0bddc9c63fbd64.jpg, createdBy=c7195518808, createdName=值班室禁止学习, createdTime=Sun Apr 14 20:17:40 CST 2024, time=2024-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194152, encodeId=e6042194152a5, content=求经验，请问大家杂志官网online和proof上的时间一致吗？还是会更晚一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16275416139, createdName=ms9000000361361306, createdTime=Tue Mar 19 21:22:36 CST 2024, time=2024-03-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2189695, encodeId=d67b21896951b, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤基础研究;肿瘤药物机理;生物信息 经验分享：23年12月29日投稿，外审约1.5月，一周后修回，修回后第2天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16275416139, createdName=ms9000000361361306, createdTime=Tue Feb 27 17:03:56 CST 2024, time=2024-02-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1184205, encodeId=16751184205f6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投稿后三个月修回（太长了等得绝望），好在没补实验，回答了几个问题，一周后重投，四天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Fri Jan 14 12:19:11 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178324, encodeId=c1c421e832465, content=投稿三四个月，不知道是否送审，发邮件也不回。垃圾期刊，千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8ca5307906, createdName=随后, createdTime=Sun Dec 31 14:40:32 CST 2023, time=2023-12-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2178036, encodeId=de6821e80363e, content=让我加实验重投，但是实验没法加，其他的部分都能修改，重投有希望吗？有建议重投后接收的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaf36517440, createdName=ms3000000696997837, createdTime=Fri Dec 29 20:10:51 CST 2023, time=2023-12-29, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2142290, encodeId=55e9214229068, content=已经投稿一个半月了，还在under review 焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Mon Jun 12 00:15:58 CST 2023, time=2023-06-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2167217, encodeId=1dc4216e21789, content=请问这个杂志是必须要有润色证明吗，官网没看到，但是评论区发现好几条要的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d98750326, createdName=ms9000001758785175, createdTime=Tue Nov 07 14:01:24 CST 2023, time=2023-11-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2161550, encodeId=67b42161550f0, content=7.11投稿，现在还是under review，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Sun Oct 08 15:20:16 CST 2023, time=2023-10-08, status=1, ipAttribution=北京)]

2024-03-08 148ca721m03暂无昵称来自湖北省

2024-1-10投稿至今两个多月还在under review 之前邮件说是审稿4-8周的啊

11 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192065, encodeId=a9272192065d0, content=2024-1-10投稿至今两个多月还在under review 之前邮件说是审稿4-8周的啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da775330396, createdName=148ca721m03暂无昵称, createdTime=Fri Mar 08 12:47:13 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198484, encodeId=f76d21984843d, content=偏重的研究方向：肿瘤 经验分享：目前这个杂志一审需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231020/9a7cba30b8b140c78120c7acf9c0c8c2/5b6deb3cbcd44c788f0bddc9c63fbd64.jpg, createdBy=c7195518808, createdName=值班室禁止学习, createdTime=Sun Apr 14 20:17:40 CST 2024, time=2024-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194152, encodeId=e6042194152a5, content=求经验，请问大家杂志官网online和proof上的时间一致吗？还是会更晚一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16275416139, createdName=ms9000000361361306, createdTime=Tue Mar 19 21:22:36 CST 2024, time=2024-03-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2189695, encodeId=d67b21896951b, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤基础研究;肿瘤药物机理;生物信息 经验分享：23年12月29日投稿，外审约1.5月，一周后修回，修回后第2天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16275416139, createdName=ms9000000361361306, createdTime=Tue Feb 27 17:03:56 CST 2024, time=2024-02-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1184205, encodeId=16751184205f6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投稿后三个月修回（太长了等得绝望），好在没补实验，回答了几个问题，一周后重投，四天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Fri Jan 14 12:19:11 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178324, encodeId=c1c421e832465, content=投稿三四个月，不知道是否送审，发邮件也不回。垃圾期刊，千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8ca5307906, createdName=随后, createdTime=Sun Dec 31 14:40:32 CST 2023, time=2023-12-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2178036, encodeId=de6821e80363e, content=让我加实验重投，但是实验没法加，其他的部分都能修改，重投有希望吗？有建议重投后接收的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaf36517440, createdName=ms3000000696997837, createdTime=Fri Dec 29 20:10:51 CST 2023, time=2023-12-29, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2142290, encodeId=55e9214229068, content=已经投稿一个半月了，还在under review 焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Mon Jun 12 00:15:58 CST 2023, time=2023-06-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2167217, encodeId=1dc4216e21789, content=请问这个杂志是必须要有润色证明吗，官网没看到，但是评论区发现好几条要的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d98750326, createdName=ms9000001758785175, createdTime=Tue Nov 07 14:01:24 CST 2023, time=2023-11-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2161550, encodeId=67b42161550f0, content=7.11投稿，现在还是under review，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Sun Oct 08 15:20:16 CST 2023, time=2023-10-08, status=1, ipAttribution=北京)]

2024-04-14 值班室禁止学习来自四川省

偏重的研究方向：肿瘤
经验分享：目前这个杂志一审需要多久？

3 0

[GetPortalCommentsPageByObjectIdResponse(id=2192065, encodeId=a9272192065d0, content=2024-1-10投稿至今两个多月还在under review 之前邮件说是审稿4-8周的啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da775330396, createdName=148ca721m03暂无昵称, createdTime=Fri Mar 08 12:47:13 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198484, encodeId=f76d21984843d, content=偏重的研究方向：肿瘤 经验分享：目前这个杂志一审需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231020/9a7cba30b8b140c78120c7acf9c0c8c2/5b6deb3cbcd44c788f0bddc9c63fbd64.jpg, createdBy=c7195518808, createdName=值班室禁止学习, createdTime=Sun Apr 14 20:17:40 CST 2024, time=2024-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194152, encodeId=e6042194152a5, content=求经验，请问大家杂志官网online和proof上的时间一致吗？还是会更晚一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16275416139, createdName=ms9000000361361306, createdTime=Tue Mar 19 21:22:36 CST 2024, time=2024-03-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2189695, encodeId=d67b21896951b, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤基础研究;肿瘤药物机理;生物信息 经验分享：23年12月29日投稿，外审约1.5月，一周后修回，修回后第2天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16275416139, createdName=ms9000000361361306, createdTime=Tue Feb 27 17:03:56 CST 2024, time=2024-02-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1184205, encodeId=16751184205f6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投稿后三个月修回（太长了等得绝望），好在没补实验，回答了几个问题，一周后重投，四天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Fri Jan 14 12:19:11 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178324, encodeId=c1c421e832465, content=投稿三四个月，不知道是否送审，发邮件也不回。垃圾期刊，千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8ca5307906, createdName=随后, createdTime=Sun Dec 31 14:40:32 CST 2023, time=2023-12-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2178036, encodeId=de6821e80363e, content=让我加实验重投，但是实验没法加，其他的部分都能修改，重投有希望吗？有建议重投后接收的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaf36517440, createdName=ms3000000696997837, createdTime=Fri Dec 29 20:10:51 CST 2023, time=2023-12-29, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2142290, encodeId=55e9214229068, content=已经投稿一个半月了，还在under review 焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Mon Jun 12 00:15:58 CST 2023, time=2023-06-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2167217, encodeId=1dc4216e21789, content=请问这个杂志是必须要有润色证明吗，官网没看到，但是评论区发现好几条要的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d98750326, createdName=ms9000001758785175, createdTime=Tue Nov 07 14:01:24 CST 2023, time=2023-11-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2161550, encodeId=67b42161550f0, content=7.11投稿，现在还是under review，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Sun Oct 08 15:20:16 CST 2023, time=2023-10-08, status=1, ipAttribution=北京)]

2024-03-19 ms9000000361361306 来自重庆

求经验，请问大家杂志官网online和proof上的时间一致吗？还是会更晚一些？

11 0

[GetPortalCommentsPageByObjectIdResponse(id=2192065, encodeId=a9272192065d0, content=2024-1-10投稿至今两个多月还在under review 之前邮件说是审稿4-8周的啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da775330396, createdName=148ca721m03暂无昵称, createdTime=Fri Mar 08 12:47:13 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198484, encodeId=f76d21984843d, content=偏重的研究方向：肿瘤 经验分享：目前这个杂志一审需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231020/9a7cba30b8b140c78120c7acf9c0c8c2/5b6deb3cbcd44c788f0bddc9c63fbd64.jpg, createdBy=c7195518808, createdName=值班室禁止学习, createdTime=Sun Apr 14 20:17:40 CST 2024, time=2024-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194152, encodeId=e6042194152a5, content=求经验，请问大家杂志官网online和proof上的时间一致吗？还是会更晚一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16275416139, createdName=ms9000000361361306, createdTime=Tue Mar 19 21:22:36 CST 2024, time=2024-03-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2189695, encodeId=d67b21896951b, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤基础研究;肿瘤药物机理;生物信息 经验分享：23年12月29日投稿，外审约1.5月，一周后修回，修回后第2天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16275416139, createdName=ms9000000361361306, createdTime=Tue Feb 27 17:03:56 CST 2024, time=2024-02-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1184205, encodeId=16751184205f6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投稿后三个月修回（太长了等得绝望），好在没补实验，回答了几个问题，一周后重投，四天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Fri Jan 14 12:19:11 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178324, encodeId=c1c421e832465, content=投稿三四个月，不知道是否送审，发邮件也不回。垃圾期刊，千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8ca5307906, createdName=随后, createdTime=Sun Dec 31 14:40:32 CST 2023, time=2023-12-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2178036, encodeId=de6821e80363e, content=让我加实验重投，但是实验没法加，其他的部分都能修改，重投有希望吗？有建议重投后接收的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaf36517440, createdName=ms3000000696997837, createdTime=Fri Dec 29 20:10:51 CST 2023, time=2023-12-29, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2142290, encodeId=55e9214229068, content=已经投稿一个半月了，还在under review 焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Mon Jun 12 00:15:58 CST 2023, time=2023-06-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2167217, encodeId=1dc4216e21789, content=请问这个杂志是必须要有润色证明吗，官网没看到，但是评论区发现好几条要的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d98750326, createdName=ms9000001758785175, createdTime=Tue Nov 07 14:01:24 CST 2023, time=2023-11-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2161550, encodeId=67b42161550f0, content=7.11投稿，现在还是under review，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Sun Oct 08 15:20:16 CST 2023, time=2023-10-08, status=1, ipAttribution=北京)]

2024-02-27 ms9000000361361306 来自重庆

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤基础研究;肿瘤药物机理;生物信息
经验分享：23年12月29日投稿，外审约1.5月，一周后修回，修回后第2天接收。

18 0

[GetPortalCommentsPageByObjectIdResponse(id=2192065, encodeId=a9272192065d0, content=2024-1-10投稿至今两个多月还在under review 之前邮件说是审稿4-8周的啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da775330396, createdName=148ca721m03暂无昵称, createdTime=Fri Mar 08 12:47:13 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198484, encodeId=f76d21984843d, content=偏重的研究方向：肿瘤 经验分享：目前这个杂志一审需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231020/9a7cba30b8b140c78120c7acf9c0c8c2/5b6deb3cbcd44c788f0bddc9c63fbd64.jpg, createdBy=c7195518808, createdName=值班室禁止学习, createdTime=Sun Apr 14 20:17:40 CST 2024, time=2024-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194152, encodeId=e6042194152a5, content=求经验，请问大家杂志官网online和proof上的时间一致吗？还是会更晚一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16275416139, createdName=ms9000000361361306, createdTime=Tue Mar 19 21:22:36 CST 2024, time=2024-03-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2189695, encodeId=d67b21896951b, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤基础研究;肿瘤药物机理;生物信息 经验分享：23年12月29日投稿，外审约1.5月，一周后修回，修回后第2天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16275416139, createdName=ms9000000361361306, createdTime=Tue Feb 27 17:03:56 CST 2024, time=2024-02-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1184205, encodeId=16751184205f6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投稿后三个月修回（太长了等得绝望），好在没补实验，回答了几个问题，一周后重投，四天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Fri Jan 14 12:19:11 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178324, encodeId=c1c421e832465, content=投稿三四个月，不知道是否送审，发邮件也不回。垃圾期刊，千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8ca5307906, createdName=随后, createdTime=Sun Dec 31 14:40:32 CST 2023, time=2023-12-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2178036, encodeId=de6821e80363e, content=让我加实验重投，但是实验没法加，其他的部分都能修改，重投有希望吗？有建议重投后接收的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaf36517440, createdName=ms3000000696997837, createdTime=Fri Dec 29 20:10:51 CST 2023, time=2023-12-29, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2142290, encodeId=55e9214229068, content=已经投稿一个半月了，还在under review 焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Mon Jun 12 00:15:58 CST 2023, time=2023-06-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2167217, encodeId=1dc4216e21789, content=请问这个杂志是必须要有润色证明吗，官网没看到，但是评论区发现好几条要的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d98750326, createdName=ms9000001758785175, createdTime=Tue Nov 07 14:01:24 CST 2023, time=2023-11-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2161550, encodeId=67b42161550f0, content=7.11投稿，现在还是under review，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Sun Oct 08 15:20:16 CST 2023, time=2023-10-08, status=1, ipAttribution=北京)]

2022-01-14 ms3000001370941770

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：投稿后三个月修回（太长了等得绝望），好在没补实验，回答了几个问题，一周后重投，四天接收。

54 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192065, encodeId=a9272192065d0, content=2024-1-10投稿至今两个多月还在under review 之前邮件说是审稿4-8周的啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da775330396, createdName=148ca721m03暂无昵称, createdTime=Fri Mar 08 12:47:13 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198484, encodeId=f76d21984843d, content=偏重的研究方向：肿瘤 经验分享：目前这个杂志一审需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231020/9a7cba30b8b140c78120c7acf9c0c8c2/5b6deb3cbcd44c788f0bddc9c63fbd64.jpg, createdBy=c7195518808, createdName=值班室禁止学习, createdTime=Sun Apr 14 20:17:40 CST 2024, time=2024-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194152, encodeId=e6042194152a5, content=求经验，请问大家杂志官网online和proof上的时间一致吗？还是会更晚一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16275416139, createdName=ms9000000361361306, createdTime=Tue Mar 19 21:22:36 CST 2024, time=2024-03-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2189695, encodeId=d67b21896951b, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤基础研究;肿瘤药物机理;生物信息 经验分享：23年12月29日投稿，外审约1.5月，一周后修回，修回后第2天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16275416139, createdName=ms9000000361361306, createdTime=Tue Feb 27 17:03:56 CST 2024, time=2024-02-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1184205, encodeId=16751184205f6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投稿后三个月修回（太长了等得绝望），好在没补实验，回答了几个问题，一周后重投，四天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Fri Jan 14 12:19:11 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178324, encodeId=c1c421e832465, content=投稿三四个月，不知道是否送审，发邮件也不回。垃圾期刊，千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8ca5307906, createdName=随后, createdTime=Sun Dec 31 14:40:32 CST 2023, time=2023-12-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2178036, encodeId=de6821e80363e, content=让我加实验重投，但是实验没法加，其他的部分都能修改，重投有希望吗？有建议重投后接收的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaf36517440, createdName=ms3000000696997837, createdTime=Fri Dec 29 20:10:51 CST 2023, time=2023-12-29, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2142290, encodeId=55e9214229068, content=已经投稿一个半月了，还在under review 焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Mon Jun 12 00:15:58 CST 2023, time=2023-06-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2167217, encodeId=1dc4216e21789, content=请问这个杂志是必须要有润色证明吗，官网没看到，但是评论区发现好几条要的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d98750326, createdName=ms9000001758785175, createdTime=Tue Nov 07 14:01:24 CST 2023, time=2023-11-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2161550, encodeId=67b42161550f0, content=7.11投稿，现在还是under review，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Sun Oct 08 15:20:16 CST 2023, time=2023-10-08, status=1, ipAttribution=北京)]

2023-12-31 随后来自湖北省

投稿三四个月，不知道是否送审，发邮件也不回。垃圾期刊，千万别投

17 0

[GetPortalCommentsPageByObjectIdResponse(id=2192065, encodeId=a9272192065d0, content=2024-1-10投稿至今两个多月还在under review 之前邮件说是审稿4-8周的啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da775330396, createdName=148ca721m03暂无昵称, createdTime=Fri Mar 08 12:47:13 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198484, encodeId=f76d21984843d, content=偏重的研究方向：肿瘤 经验分享：目前这个杂志一审需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231020/9a7cba30b8b140c78120c7acf9c0c8c2/5b6deb3cbcd44c788f0bddc9c63fbd64.jpg, createdBy=c7195518808, createdName=值班室禁止学习, createdTime=Sun Apr 14 20:17:40 CST 2024, time=2024-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194152, encodeId=e6042194152a5, content=求经验，请问大家杂志官网online和proof上的时间一致吗？还是会更晚一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16275416139, createdName=ms9000000361361306, createdTime=Tue Mar 19 21:22:36 CST 2024, time=2024-03-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2189695, encodeId=d67b21896951b, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤基础研究;肿瘤药物机理;生物信息 经验分享：23年12月29日投稿，外审约1.5月，一周后修回，修回后第2天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16275416139, createdName=ms9000000361361306, createdTime=Tue Feb 27 17:03:56 CST 2024, time=2024-02-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1184205, encodeId=16751184205f6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投稿后三个月修回（太长了等得绝望），好在没补实验，回答了几个问题，一周后重投，四天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Fri Jan 14 12:19:11 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178324, encodeId=c1c421e832465, content=投稿三四个月，不知道是否送审，发邮件也不回。垃圾期刊，千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8ca5307906, createdName=随后, createdTime=Sun Dec 31 14:40:32 CST 2023, time=2023-12-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2178036, encodeId=de6821e80363e, content=让我加实验重投，但是实验没法加，其他的部分都能修改，重投有希望吗？有建议重投后接收的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaf36517440, createdName=ms3000000696997837, createdTime=Fri Dec 29 20:10:51 CST 2023, time=2023-12-29, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2142290, encodeId=55e9214229068, content=已经投稿一个半月了，还在under review 焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Mon Jun 12 00:15:58 CST 2023, time=2023-06-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2167217, encodeId=1dc4216e21789, content=请问这个杂志是必须要有润色证明吗，官网没看到，但是评论区发现好几条要的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d98750326, createdName=ms9000001758785175, createdTime=Tue Nov 07 14:01:24 CST 2023, time=2023-11-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2161550, encodeId=67b42161550f0, content=7.11投稿，现在还是under review，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Sun Oct 08 15:20:16 CST 2023, time=2023-10-08, status=1, ipAttribution=北京)]

2023-12-29 ms3000000696997837 来自安徽省

让我加实验重投，但是实验没法加，其他的部分都能修改，重投有希望吗？有建议重投后接收的吗？

16 0

[GetPortalCommentsPageByObjectIdResponse(id=2192065, encodeId=a9272192065d0, content=2024-1-10投稿至今两个多月还在under review 之前邮件说是审稿4-8周的啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da775330396, createdName=148ca721m03暂无昵称, createdTime=Fri Mar 08 12:47:13 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198484, encodeId=f76d21984843d, content=偏重的研究方向：肿瘤 经验分享：目前这个杂志一审需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231020/9a7cba30b8b140c78120c7acf9c0c8c2/5b6deb3cbcd44c788f0bddc9c63fbd64.jpg, createdBy=c7195518808, createdName=值班室禁止学习, createdTime=Sun Apr 14 20:17:40 CST 2024, time=2024-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194152, encodeId=e6042194152a5, content=求经验，请问大家杂志官网online和proof上的时间一致吗？还是会更晚一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16275416139, createdName=ms9000000361361306, createdTime=Tue Mar 19 21:22:36 CST 2024, time=2024-03-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2189695, encodeId=d67b21896951b, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤基础研究;肿瘤药物机理;生物信息 经验分享：23年12月29日投稿，外审约1.5月，一周后修回，修回后第2天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16275416139, createdName=ms9000000361361306, createdTime=Tue Feb 27 17:03:56 CST 2024, time=2024-02-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1184205, encodeId=16751184205f6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投稿后三个月修回（太长了等得绝望），好在没补实验，回答了几个问题，一周后重投，四天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Fri Jan 14 12:19:11 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178324, encodeId=c1c421e832465, content=投稿三四个月，不知道是否送审，发邮件也不回。垃圾期刊，千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8ca5307906, createdName=随后, createdTime=Sun Dec 31 14:40:32 CST 2023, time=2023-12-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2178036, encodeId=de6821e80363e, content=让我加实验重投，但是实验没法加，其他的部分都能修改，重投有希望吗？有建议重投后接收的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaf36517440, createdName=ms3000000696997837, createdTime=Fri Dec 29 20:10:51 CST 2023, time=2023-12-29, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2142290, encodeId=55e9214229068, content=已经投稿一个半月了，还在under review 焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Mon Jun 12 00:15:58 CST 2023, time=2023-06-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2167217, encodeId=1dc4216e21789, content=请问这个杂志是必须要有润色证明吗，官网没看到，但是评论区发现好几条要的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d98750326, createdName=ms9000001758785175, createdTime=Tue Nov 07 14:01:24 CST 2023, time=2023-11-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2161550, encodeId=67b42161550f0, content=7.11投稿，现在还是under review，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Sun Oct 08 15:20:16 CST 2023, time=2023-10-08, status=1, ipAttribution=北京)]

2023-06-12 1489114dm38(暂无昵称) 来自四川省

已经投稿一个半月了，还在under review 焦虑

31 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192065, encodeId=a9272192065d0, content=2024-1-10投稿至今两个多月还在under review 之前邮件说是审稿4-8周的啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da775330396, createdName=148ca721m03暂无昵称, createdTime=Fri Mar 08 12:47:13 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198484, encodeId=f76d21984843d, content=偏重的研究方向：肿瘤 经验分享：目前这个杂志一审需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231020/9a7cba30b8b140c78120c7acf9c0c8c2/5b6deb3cbcd44c788f0bddc9c63fbd64.jpg, createdBy=c7195518808, createdName=值班室禁止学习, createdTime=Sun Apr 14 20:17:40 CST 2024, time=2024-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194152, encodeId=e6042194152a5, content=求经验，请问大家杂志官网online和proof上的时间一致吗？还是会更晚一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16275416139, createdName=ms9000000361361306, createdTime=Tue Mar 19 21:22:36 CST 2024, time=2024-03-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2189695, encodeId=d67b21896951b, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤基础研究;肿瘤药物机理;生物信息 经验分享：23年12月29日投稿，外审约1.5月，一周后修回，修回后第2天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16275416139, createdName=ms9000000361361306, createdTime=Tue Feb 27 17:03:56 CST 2024, time=2024-02-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1184205, encodeId=16751184205f6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投稿后三个月修回（太长了等得绝望），好在没补实验，回答了几个问题，一周后重投，四天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Fri Jan 14 12:19:11 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178324, encodeId=c1c421e832465, content=投稿三四个月，不知道是否送审，发邮件也不回。垃圾期刊，千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8ca5307906, createdName=随后, createdTime=Sun Dec 31 14:40:32 CST 2023, time=2023-12-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2178036, encodeId=de6821e80363e, content=让我加实验重投，但是实验没法加，其他的部分都能修改，重投有希望吗？有建议重投后接收的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaf36517440, createdName=ms3000000696997837, createdTime=Fri Dec 29 20:10:51 CST 2023, time=2023-12-29, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2142290, encodeId=55e9214229068, content=已经投稿一个半月了，还在under review 焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Mon Jun 12 00:15:58 CST 2023, time=2023-06-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2167217, encodeId=1dc4216e21789, content=请问这个杂志是必须要有润色证明吗，官网没看到，但是评论区发现好几条要的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d98750326, createdName=ms9000001758785175, createdTime=Tue Nov 07 14:01:24 CST 2023, time=2023-11-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2161550, encodeId=67b42161550f0, content=7.11投稿，现在还是under review，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Sun Oct 08 15:20:16 CST 2023, time=2023-10-08, status=1, ipAttribution=北京)]

2023-11-07 ms9000001758785175 来自上海

请问这个杂志是必须要有润色证明吗，官网没看到，但是评论区发现好几条要的

67 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192065, encodeId=a9272192065d0, content=2024-1-10投稿至今两个多月还在under review 之前邮件说是审稿4-8周的啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da775330396, createdName=148ca721m03暂无昵称, createdTime=Fri Mar 08 12:47:13 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198484, encodeId=f76d21984843d, content=偏重的研究方向：肿瘤 经验分享：目前这个杂志一审需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231020/9a7cba30b8b140c78120c7acf9c0c8c2/5b6deb3cbcd44c788f0bddc9c63fbd64.jpg, createdBy=c7195518808, createdName=值班室禁止学习, createdTime=Sun Apr 14 20:17:40 CST 2024, time=2024-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194152, encodeId=e6042194152a5, content=求经验，请问大家杂志官网online和proof上的时间一致吗？还是会更晚一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16275416139, createdName=ms9000000361361306, createdTime=Tue Mar 19 21:22:36 CST 2024, time=2024-03-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2189695, encodeId=d67b21896951b, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤基础研究;肿瘤药物机理;生物信息 经验分享：23年12月29日投稿，外审约1.5月，一周后修回，修回后第2天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16275416139, createdName=ms9000000361361306, createdTime=Tue Feb 27 17:03:56 CST 2024, time=2024-02-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1184205, encodeId=16751184205f6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：投稿后三个月修回（太长了等得绝望），好在没补实验，回答了几个问题，一周后重投，四天接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Fri Jan 14 12:19:11 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178324, encodeId=c1c421e832465, content=投稿三四个月，不知道是否送审，发邮件也不回。垃圾期刊，千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8ca5307906, createdName=随后, createdTime=Sun Dec 31 14:40:32 CST 2023, time=2023-12-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2178036, encodeId=de6821e80363e, content=让我加实验重投，但是实验没法加，其他的部分都能修改，重投有希望吗？有建议重投后接收的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaf36517440, createdName=ms3000000696997837, createdTime=Fri Dec 29 20:10:51 CST 2023, time=2023-12-29, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2142290, encodeId=55e9214229068, content=已经投稿一个半月了，还在under review 焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Mon Jun 12 00:15:58 CST 2023, time=2023-06-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2167217, encodeId=1dc4216e21789, content=请问这个杂志是必须要有润色证明吗，官网没看到，但是评论区发现好几条要的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d98750326, createdName=ms9000001758785175, createdTime=Tue Nov 07 14:01:24 CST 2023, time=2023-11-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2161550, encodeId=67b42161550f0, content=7.11投稿，现在还是under review，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Sun Oct 08 15:20:16 CST 2023, time=2023-10-08, status=1, ipAttribution=北京)]

2023-10-08 Cynthia开心来自北京

7.11投稿，现在还是under review，急死了

22 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务